IL-21 enhances the antibody-dependent cell-mediated cytotoxicity (ADCC) of NK cells and stimulates their secretion of IFN-γ and chemokines for recruiting activated T cells, and its combination with cetuximab reduces tumor load in mice 120. Here, IFNG is linked to neoplasm.